首页> 外文OA文献 >Vascular Endothelial Growth Factor and Kinase Domain Region Receptor Are Involved in Both Seminiferous Cord Formation and Vascular Development During Testis Morphogenesis in the Rat
【2h】

Vascular Endothelial Growth Factor and Kinase Domain Region Receptor Are Involved in Both Seminiferous Cord Formation and Vascular Development During Testis Morphogenesis in the Rat

机译:血管内皮生长因子和激酶结构域受体参与大鼠睾丸形态发生过程中的生精线形成和血管发育

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Morphological male sex determination is dependent on migration of endothelial and preperitubular cells from the adjacent mesonephros into the developing testis. Our hypothesis is that VEGFA and its receptor KDR are necessary for both testicular cord formation and neovascularization. The Vegfa gene has 8 exons with many splice variants. Vegfa120, Vegfa164, and Vegfa188 mRNA isoforms were detected on Embryonic Day (E) 13.5 (plug date = E0) in the rat. Vegfa120, Vegfa144, Vegfa164, Vegfa188, and Vegfa205 mRNA were detected at E18 and Postnatal Day 3 (P3). Kdr mRNA was present on E13.5, whereas Fms-like tyrosine kinase 1 receptor (Flt1) mRNA was not detected until E18. VEGFA protein was localized to Sertoli cells at cord formation and KDR to germ and interstitial cells. The VEGFA signaling inhibitors SU1498 (40 μM) and VEGFR-TKI (8 μM) inhibited cord formation in E13 testis cultures with 90% reduced vascular density (P \u3c 0.01) in VEGFR-TKI-treated organs. Furthermore, Je-11 (10 μM), an antagonist to VEGFA, also perturbed cord formation and inhibited vascular density by more than 50% (P \u3c 0.01). To determine signal transduction pathways involved in VEGFA’s regulation of testis morphogenesis, E13 testis were treated with LY 294002 (15 μM), a phosphoinositide 3-kinase (PI3K) pathway inhibitor, resulting in inhibition of both vascular density (46%) and cord formation. Thus, we support our hypothesis and conclude that VEGFA, secreted by the Sertoli cell, is involved in both neovascularization and cord formation and potentially acts through the PI3K pathway during testis morphogenesis to elicit its effects.
机译:男性形态的确定取决于内皮细胞和周皮细胞从相邻的中肾向发育中的睾丸的迁移。我们的假设是,VEGFA及其受体KDR对于睾丸索形成和新血管形成都是必需的。 Vegfa基因有8个外显子,具有许多剪接变体。在大鼠的胚胎日(E)13.5(插入日期= E0)检测到Vegfa120,Vegfa164和Vegfa188 mRNA亚型。在E18和出生后第3天(P3)检测到Vegfa120,Vegfa144,Vegfa164,Vegfa188和Vegfa205 mRNA。 Kdr mRNA存在于E13.5上,而直到E18才检测到Fms样酪氨酸激酶1受体(Flt1)mRNA。 VEGFA蛋白在脐带形成时定位于Sertoli细胞,KDR定位在生殖细胞和间质细胞。 VEGFA信号抑制剂SU1498(40μM)和VEGFR-TKI(8μM)抑制了E13睾丸培养物中的脐带形成,在VEGFR-TKI处理的器官中血管密度降低了90%(P <0.01)。此外,VEGFA拮抗剂Je-11(10μM)也干扰了脐带形成,并抑制了50%以上的血管密度(P <0.01)。为了确定涉及VEGFA调节睾丸形态发生的信号转导途径,用磷酸肌醇3激酶(PI3K)途径抑制剂LY 294002(15μM)处理E13睾丸,从而抑制血管密度(46%)和脐带形成。因此,我们支持我们的假设并得出结论,由支持细胞分泌的VEGFA参与新生血管形成和脐带形成,并可能在睾丸形态发生过程中通过PI3K途径发挥作用,以引起其作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号